CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 57 enrolled
Drug / intervention
FLACS +3 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03479944
NCT03479944N/ACompleted
CompareCT.gov

Clinical Evaluation of FLACS (Femtosecond Laser Assisted Cataract Surgery) With Combination of LenSx® and Centurion®

Alcon Research·interventional·Posted Mar 27, 2018·Updated Dec 16, 2019

In Brief

A clinical study evaluating FLACS, Manual conventional surgery, and 2 other interventions for Cataract. Completed, enrolled 57 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate cumulative dissipated energy (CDE), endothelial cell loss, and average torsional amplitude with combination of LenSx® and Centurion® compared to conventional cataract surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesJapan
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 27, 2018
Enrollment StartAug 22, 2018
Primary CompletionNov 19, 2018
Study CompletionMay 17, 2019
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 8.3 years ago

Interventions

FLACSprocedure

Femtosecond laser assisted cataract surgery consisting of LenSx® and Centurion® combination

Manual conventional surgeryprocedure

Removal of cataractous lens by phacoemulsification

CENTURION® Vision Systemdevice

Phacoemulsification aspiration platform for use during cataract surgery

LenSx®device

Femtosecond laser system used for continuous curvilinear capsulorhexis (CCC) and lens fragmentation during cataract surgery